ZYVEarnings•globenewswire•
ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones
Sentiment:Neutral (55)
Summary
KEY HIGHLIGHTS
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 13, 2025 by globenewswire